Saupe M, Rauschenberger L, Preu M, Oswald S, Fussek S, Zimmermann U et al
Rybelsus2 may potentially result in weight loss as a side effect
812 Diabetic kidney disease occurs in patients with T2DM as a consequence of reduced kidney function, triggered by hypertensive nephrosclerosis and unresolved acute renal failure as the main culminating reasons
Most adverse events were mild to moderate and gastrointestinal in nature, resolving as dosing stabilised
Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the medications to diagnose, cure or prevent disease
(2019) reported that urinary NGAL accurately predicted AKI development in 27 subjects, identifying NGAL as a strong early marker of AKI. Despite this, managing CKD in liver transplant recipients remains challenging, with limited options to prevent or mitigate the progression of kidney damage